Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta
about
Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domainModulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core proteinRepression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory GenesResponses of Nontransformed Human Hepatocytes to Conditional Expression of Full-Length Hepatitis C Virus Open Reading FrameMouse models for the study of HCV infection and virus–host interactionsHCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA MiceFunctional characterization of core genes from patients with acute hepatitis C virus infectionAdditive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activityModulation of NF-κB signalling by microbial pathogensCellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patientsHerpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signalingMerkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Hepatitis C virus-induced hepatocellular carcinomaBetulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression.Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease.Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65)Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organsdsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cellsent-kaur-16-en-19-oic Acid, isolated from the roots of Aralia continentalis, induces activation of Nrf2Lipopolysaccharide-dependent interaction between PU.1 and c-Jun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages.NF-kappaB signaling, liver disease and hepatoprotective agents.Role of nuclear factor kappaB in liver health and disease.Tumour necrosis factor in infectious disease.Influenza viral manipulation of sphingolipid metabolism and signaling to modulate host defense system.The hepatitis C virus protein NS3 suppresses TNF-α-stimulated activation of NF-κB by targeting LUBAC.Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signalingRole of nuclear factor-κB in oxidative stress associated with rabies virus infection of adult rat dorsal root ganglion neurons.Porcine reproductive and respiratory syndrome virus nucleocapsid protein modulates interferon-β production by inhibiting IRF3 activation in immortalized porcine alveolar macrophages.Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line.Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection.Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages.Hepatitis C virus core and NS3 antigens induced conjunctival inflammation via toll-like receptor-mediated signalingSphingosine kinase 1 regulates measles virus replication.HCV enters the twenty-first century.Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin.
P2860
Q24301056-D4299DC5-2C00-4DAD-ABBC-799132366AA8Q24336062-893BE9CF-83F4-44D3-A15D-50EAC626ADDFQ27478031-EDD06032-2CF2-43B4-888F-AE7AC630DF2FQ27482327-E64EB74F-3FF6-4B38-BF3A-B36B2D67043FQ27486807-6BB0C0CF-A589-4676-ABEE-387462CECF8CQ27487963-0474B766-92B6-4801-B977-B13BE776B245Q27490973-030BB5DF-8CED-4D76-9084-E7BEC03CB786Q28219414-B8F30529-5D65-4D77-A646-F602B312572AQ28709497-2FCF6C02-3379-485B-BC96-01F141E3577AQ33584149-D6E96385-5001-4244-A253-32F4DB191C32Q34178155-0001798D-A9C9-4187-BF38-7E75853D685CQ34309882-CEB7C396-596B-4DB0-A32D-53E6F38FD6E5Q34765478-270130E9-156D-4338-806F-6ED1B3645020Q35619104-D2BDAE2C-247B-4C80-9056-EC6F4C789B0BQ35824057-253D6486-4DA5-4844-A2E2-E027C021F389Q36036224-B2F2AF22-B1B6-4730-8F34-C59AE3B632AAQ36055547-5C46EE0F-CC60-4B76-86CE-4DDEC87B7FA2Q36099463-E2066D68-FE93-4A74-950D-A834560C8B7EQ36253643-811B4528-66AC-49BC-922D-CACDF3419816Q36432681-B8CC54AF-F8C6-4054-BFFC-D962D2967C4FQ36675284-158F4A4E-F4DE-4B56-B12C-98A911C67C45Q36739310-873DB268-DA2D-4C50-8572-C2BA55270CD0Q37190211-25F1A379-9675-4922-8015-E8CB81420EFAQ37302741-210D3697-AA87-4314-8461-074688B653E5Q37720780-F5403011-0DE2-4A3A-A19D-0F691F1243F9Q38086506-2E612234-412A-4D1A-8D42-EC291539DC22Q38199691-653FC505-95CA-4DC8-B479-600A3F34AD2DQ38420434-0EE97629-9135-403B-9C34-99F149385895Q38959978-E2956A2C-A2C6-4E24-9BC5-9C0B1C15264AQ39083904-A8A31B57-03C8-490D-97C0-8C65E4076B3FQ39343063-2F8CE56D-E389-48D5-8D53-4D62C336A37FQ39468134-2FE21FB3-29BA-4BDF-95CA-015D90D5B937Q39588175-999BA359-18F8-4B7F-8671-4B301C48CFD8Q39994610-83829444-FF13-4001-A50A-A19163D724F6Q40013272-284B37AE-5B90-4E3C-ADB7-991274B5090EQ40183618-44432EF1-8CA4-4A0C-8658-75E1115A63C2Q41685645-F25B6C29-2565-4F8C-8B52-1A07EA3CF35DQ41934199-C64405B2-B013-4BA3-AA08-F5D6029A635AQ42281701-95C0B511-4A7E-4288-ADDC-C435D9A8767FQ43033715-F596DC7E-FA3D-4D78-9A58-EE1CDBD7BF3E
P2860
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hepatitis C Virus Core Protein ...... ct Interaction with I B Kinase
@nl
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@ast
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@en
type
label
Hepatitis C Virus Core Protein ...... ct Interaction with I B Kinase
@nl
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@ast
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@en
prefLabel
Hepatitis C Virus Core Protein ...... ct Interaction with I B Kinase
@nl
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@ast
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@en
P2093
P2860
P1433
P1476
Hepatitis C virus core protein ...... ction with IkappaB kinase beta
@en
P2093
John W Christman
Minjae Kwon
Myungsoo Joo
Ruxana T Sadikot
Timothy S Blackwell
Young S Hahn
P2860
P304
P356
10.1128/JVI.79.12.7648-7657.2005
P577
2005-06-01T00:00:00Z